T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Financials | 16.84% |
| 3 | Technology | 15.92% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
AngioDynamics
ANGO
$646M
| $3.02M | ﹤0.01% |
176,552
+161,650
| +1,085% | +$2.72M |
|
|
WPG
1502
DELISTED
Washington Prime Group Inc.
WPG
| $3.01M | ﹤0.01% |
40,109
+2,811
| +8% | +$218K |
|
1503
American Financial Group
AFG
$12.1B
| $2.98M | ﹤0.01% |
28,839
+595
| +2% | +$60.5K |
|
1504
Ovid Therapeutics
OVID
$519M
| $2.97M | ﹤0.01% |
361,640
| – | – |
|
1505
Gentex
GNTX
$4.99B
| $2.93M | ﹤0.01% |
147,856
+3,426
| +2% | +$62.3K |
|
1506
National Fuel Gas
NFG
$7.78B
| $2.91M | ﹤0.01% |
51,429
+5
| +0% | +$290 |
|
1507
Essential Utilities
WTRG
$11.4B
| $2.87M | ﹤0.01% |
86,459
-5,470
| -6% | -$183K |
|
1508
News Corp Class B
NWS
$17.8B
| $2.86M | ﹤0.01% |
209,320
-9,000
| -4% | -$125K |
|
1509
Dick's Sporting Goods
DKS
$18.1B
| $2.82M | ﹤0.01% |
104,565
-1,975,039
| -95% | -$62.8M |
|
1510
Thor Industries
THO
$4.11B
| $2.81M | ﹤0.01% |
22,311
+132
| +0.6% | +$14.2K |
|
|
CSOD
1511
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $2.77M | ﹤0.01% |
68,082
-2,171
| -3% | -$80.3K |
|
1512
NNN REIT
NNN
$8.87B
| $2.73M | ﹤0.01% |
65,584
+5,400
| +9% | +$221K |
|
|
Y
1513
DELISTED
Alleghany Corp
Y
| $2.71M | ﹤0.01% |
4,891
| – | – |
|
1514
CRISPR Therapeutics
CRSP
$5.15B
| $2.71M | ﹤0.01% |
+151,510
| New | +$2.75M |
|
1515
Arista Networks
ANET
$254B
| $2.7M | ﹤0.01% |
227,664
+96
| +0% | +$1K |
|
|
CHFN
1516
DELISTED
Charter Financial Corp
CHFN
| $2.69M | ﹤0.01% |
145,017
| – | – |
|
1517
Reinsurance Group of America
RGA
$16.2B
| $2.65M | ﹤0.01% |
18,953
+3
| +0% | +$406 |
|
1518
AGNC Investment
AGNC
$13.1B
| $2.64M | ﹤0.01% |
121,677
+101
| +0.1% | +$2.16K |
|
|
BRCD
1519
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $2.62M | ﹤0.01% |
219,196
+21
| +0% | +$259 |
|
1520
Starwood Property Trust
STWD
$6.12B
| $2.59M | ﹤0.01% |
119,329
+4,344
| +4% | +$95.7K |
|
1521
Sonoco
SON
$5.73B
| $2.53M | ﹤0.01% |
50,125
+9,410
| +23% | +$464K |
|
1522
Old Republic International
ORI
$10.3B
| $2.48M | ﹤0.01% |
126,075
-35,054
| -22% | -$679K |
|
1523
Trinity Industries
TRN
$2.35B
| $2.47M | ﹤0.01% |
107,468
-7,445
| -6% | -$154K |
|
|
TCF
1524
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.47M | ﹤0.01% |
47,208
+2,800
| +6% | +$134K |
|
1525
The Greenbrier Companies
GBX
$1.43B
| $2.46M | ﹤0.01% |
51,076
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.